Elizabeth Holmes

Elizabeth Anne Holmes (born February 3, 1984) is an American former businesswoman and convicted felon who founded and served as CEO of Theranos, a now-defunct health technology company. Once celebrated as the youngest self-made female billionaire in the United States with a net worth of $4.5 billion, Holmes was convicted of defrauding investors and is currently serving an 11-year federal prison sentence.

Holmes founded Theranos in 2003 at age 19 after dropping out of Stanford University, claiming to have developed revolutionary blood testing technology that could run hundreds of tests from just a few drops of blood. The company attracted over $700 million in investment and reached a peak valuation of $9 billion in 2014. However, investigative reporting by The Wall Street Journal in 2015 revealed that the technology did not work as claimed, leading to the company's collapse and Holmes's subsequent criminal prosecution.

Early life and education

Elizabeth Anne Holmes was born on February 3, 1984, in Washington, D.C., to Christian Rasmus Holmes IV and Noel Anne Daoust. Her father worked as a vice president at Enron before its collapse and later held positions at government agencies including USAID. Her mother was a Congressional committee staffer. Holmes is a descendant of Charles Louis Fleischmann, founder of the Fleischmann's Yeast company, and is also related to the Fleischmann and Holmes families of Cincinnati, which have connections to various medical and business dynasties.

Holmes attended St. John's School in Houston, Texas, where she excelled academically and developed an early interest in computers and business. During high school, she began learning Mandarin Chinese and started a business selling C++ compilers to Chinese universities, reportedly earning $30,000. This early entrepreneurial experience shaped her ambitions to build a major technology company.

In 2002, Holmes enrolled at Stanford University to study chemical engineering. During her freshman year, she worked in the laboratory of Channing Robertson, a distinguished chemical engineering professor who would become a key supporter and later a Theranos board member. That summer, she interned at the Genome Institute of Singapore, where she worked on research related to Severe Acute Respiratory Syndrome (SARS) blood testing. This experience inspired her interest in blood diagnostics.

Holmes has stated publicly that she was sexually assaulted during her time at Stanford, an experience she later cited as one reason for leaving the university. In 2003, during her sophomore year, she filed her first patent for a wearable drug-delivery patch and dropped out of Stanford to found a company that would become Theranos.

Theranos

Founding and early years

In 2003, at age 19, Holmes founded Real-Time Cures in Palo Alto, California, using her Stanford tuition money as seed funding. She later renamed the company Theranos, a portmanteau of "therapy" and "diagnosis." Holmes claimed that her fear of needles motivated her vision to revolutionize blood testing by eliminating the need for traditional venous blood draws.

Holmes's initial pitch promised technology that could run comprehensive blood tests using just a few drops of blood from a finger prick, with results available in minutes rather than days. She envisioned Theranos devices in every home, pharmacy, and hospital, "democratizing" healthcare by making blood testing more accessible and affordable.

Professor Channing Robertson became one of Theranos's first board members and its first consultant, lending academic credibility to the venture. Holmes was skilled at attracting attention and investment, cultivating a carefully crafted image that included wearing black turtlenecks in deliberate imitation of Apple co-founder Steve Jobs.

Growth and $9 billion valuation

Between 2004 and 2010, Theranos raised substantial capital from venture investors despite operating in extreme secrecy. The company's board of directors eventually became notable for its distinguished membership, though critics pointed out the lack of medical or technology expertise among the directors.

In 2011, Holmes was introduced to former Secretary of State George Shultz, who joined the Theranos board. Through Shultz's connections, she recruited an extraordinary group of prominent figures including:

• Henry Kissinger - Former Secretary of State
• William Perry - Former Secretary of Defense
• Sam Nunn - Former U.S. Senator
• Bill Frist - Former Senate Majority Leader and heart-transplant surgeon
• James Mattis - Retired Marine Corps General (later Secretary of Defense under Trump)
• Richard Kovacevich - Former Wells Fargo Chairman and CEO
• Riley P. Bechtel - Chairman of Bechtel Group
• Gary Roughead - Retired Admiral, U.S. Navy

By 2014, Theranos had raised over $400 million and was valued at $9 billion, making Holmes's 50% stake worth approximately $4.5 billion. Forbes named her the youngest self-made female billionaire in America. The company announced partnerships with Walgreens to install Theranos "Wellness Centers" in pharmacies and with Safeway to place testing facilities in grocery stores.

Major investors who would later lose their investments included:

• The Walton family (Walmart heirs) - $150 million
• Rupert Murdoch - $125 million
• Betsy DeVos family - $100 million
• The Cox family - $100 million
• Larry Ellison (Oracle co-founder) - undisclosed amount

Exposure and collapse

In October 2015, The Wall Street Journal reporter John Carreyrou published a devastating investigative article revealing that Theranos's proprietary blood-testing machines, called Edison devices, did not work as advertised. The company was secretly using modified conventional machines from companies like Siemens for most of its tests, while the Edison devices produced unreliable results.

Key revelations from Carreyrou's investigation, later expanded in his book Bad Blood: Secrets and Lies in a Silicon Valley Startup (2018), included:

• Theranos devices produced inconsistent and inaccurate results
• The company voided tens of thousands of blood tests after discovering errors
• Employees who raised concerns were silenced, intimidated, or terminated
• Patients received incorrect diagnoses that affected their medical decisions
• The company engaged in elaborate demonstrations using rigged equipment

A critical source for Carreyrou was Tyler Shultz, grandson of board member George Shultz. Tyler had worked at Theranos from 2013 to 2014 and witnessed the discrepancies between the company's claims and reality. Despite pressure from his grandfather and aggressive legal threats from Theranos, Tyler persisted in speaking to journalists and regulators.

Following the Wall Street Journal exposé, the Centers for Medicare and Medicaid Services (CMS) investigated Theranos's laboratory in Newark, California. In 2016, CMS found serious deficiencies and threatened to ban Holmes and Theranos from the blood-testing industry for two years. The company's Walgreens partnership dissolved, and investors began demanding answers.

In March 2018, the Securities and Exchange Commission charged Holmes and Theranos president Ramesh "Sunny" Balwani with "massive fraud" through false claims about the company's technology, business, and finances. Holmes settled with the SEC, agreeing to pay a $500,000 fine, return 18.9 million shares, and accept a 10-year ban from serving as an officer or director of any public company.

Theranos officially dissolved in September 2018, and its remaining assets were used to pay creditors. The final liquidation rendered all investments in the company worthless.

Relationship with Ramesh "Sunny" Balwani

Holmes met Ramesh "Sunny" Balwani in 2002 during a Stanford summer program trip to Beijing. At the time, Holmes was 18 and a high school senior, while Balwani was 37, married, and pursuing an MBA at the University of California, Berkeley. They began a romantic relationship around 2003 or 2004, coinciding with Holmes founding Theranos.

Balwani joined Theranos in 2009 as president and chief operating officer despite having no background in biological sciences or medical devices. He had previously worked in software and made substantial money from the sale of a company called CommerceBid.com during the dot-com boom. Balwani invested approximately $12 million of his own money in Theranos.

The romantic relationship between Holmes and Balwani was kept secret from Theranos investors, board members, and business partners for over a decade. Former employees described Balwani as overbearing, quick-tempered, and paranoid about industrial espionage. The couple lived together in a Palo Alto condominium while running the company together.

During her trial, Holmes testified that Balwani psychologically and physically abused her throughout their relationship, including forced sex. She claimed he was extremely controlling, dictating what she ate, when she slept, who she could be friends with, and how she should behave. Holmes alleged that Balwani told her she needed to "kill the person" she was and become "a new Elizabeth." Balwani has denied all abuse allegations through his attorneys.

Their relationship ended around 2016, during the period when Theranos was under investigation. Balwani departed from the company in 2016.

Criminal prosecution and imprisonment

Indictment and trial

In June 2018, Holmes and Balwani were indicted by a federal grand jury on nine counts of wire fraud and two counts of conspiracy to commit wire fraud. The charges alleged that they engaged in schemes to defraud investors, doctors, and patients.

Holmes's trial began in August 2021 in San Jose, California, before U.S. District Judge Edward Davila. The trial lasted approximately four months and featured testimony from former Theranos employees, investors, patients, and experts. Key prosecution witnesses included former employees who described a culture of secrecy and intimidation, as well as investors who testified about misrepresentations Holmes made to secure their money.

Holmes took the stand in her own defense, presenting herself as a young entrepreneur who genuinely believed in her company's mission and technology. She blamed Balwani for many of the company's problems and testified about the alleged abuse she suffered at his hands. Her defense team argued that Holmes lacked criminal intent and was herself a victim of manipulation.

Conviction and sentence

On January 3, 2022, the jury found Holmes guilty on four of eleven counts: one count of conspiracy to commit wire fraud against investors and three counts of wire fraud involving specific investors. She was acquitted on charges related to defrauding patients. The jury deadlocked on three counts related to individual investors.

On November 18, 2022, Judge Davila sentenced Holmes to 135 months (11 years and 3 months) in federal prison, plus three years of supervised release. She was also ordered to pay $452 million in restitution to victims, with responsibility shared between her and Balwani.

Holmes reported to Federal Prison Camp Bryan in Texas on May 30, 2023, to begin serving her sentence. Her release date has been adjusted several times due to good behavior credits; as of 2024, her projected release date is March 2032.

Appeals

Holmes's legal team appealed her conviction, arguing that errors were made during the trial. In February 2025, the Ninth U.S. Circuit Court of Appeals rejected her arguments and affirmed her conviction and sentence. In May 2025, the appellate court denied her request for a rehearing before a larger panel of judges. Her remaining option is to petition the U.S. Supreme Court.

Balwani was tried separately and convicted on all twelve counts in July 2022. He was sentenced to nearly 13 years in prison, longer than Holmes's sentence.

Public image and persona

Holmes cultivated a carefully constructed public image that became central to Theranos's marketing and fundraising success. Her signature look included black turtleneck sweaters, a deliberate imitation of Apple co-founder Steve Jobs. Former Theranos employee Ana Arriola has taken credit for suggesting the wardrobe change, though Holmes later claimed she had worn black turtlenecks since childhood.

Holmes's unusually deep voice became a subject of significant public discussion. Multiple former colleagues and her Stanford professor stated that her natural voice was higher-pitched and that she adopted the lower register deliberately. Former employees reported occasionally hearing her slip into a more natural, higher voice. In a 2023 New York Times interview from prison, Holmes spoke in her natural, higher-pitched voice, confirming that the deep voice was an affectation.

Her mannerisms, including unblinking eye contact and intense focus, became widely noted and occasionally parodied. These traits were dramatized in the Hulu series The Dropout (2022), starring Amanda Seyfried, who won an Emmy Award for her portrayal of Holmes.

Personal life

Holmes met William "Billy" Evans at a Fleet Week party in 2017, while she was under federal investigation. Evans is an heir to the Evans Hotels hospitality company in San Diego, which his grandparents founded in 1953. He graduated from MIT with an economics degree in 2015 and worked at LinkedIn and Luminar Technologies before their relationship.

Holmes and Evans became engaged in early 2019, and they married in a private ceremony that June. According to reports, the wedding was kept secret and no Theranos employees or associates were invited.

The couple has two children: a son named William Holmes Evans, born in July 2021, and a daughter named Invicta, born in early 2023. The pregnancy and birth of her first child caused delays in her trial proceedings. Holmes gave birth to her second child after her conviction but before beginning her prison sentence.

Evans has been publicly supportive of Holmes throughout her legal troubles. Before her sentencing, he submitted a 12-page letter to the court describing her as a loving partner and mother with "limitless" potential to change the world. His family was initially reported to be skeptical of the relationship, with sources claiming they believed he had been "brainwashed."

Since Holmes's incarceration, Evans has been the primary caretaker of their two children in the San Diego area.

In popular culture

Holmes and the Theranos scandal have been the subject of numerous media adaptations:

• Bad Blood (2018) - John Carreyrou's bestselling book documenting his investigation
• The Inventor: Out for Blood in Silicon Valley (2019) - HBO documentary directed by Alex Gibney
• The Dropout (2022) - Hulu limited series starring Amanda Seyfried, who won the Primetime Emmy Award for Outstanding Lead Actress in a Limited or Anthology Series or Movie
• Bad Blood - Forthcoming feature film based on Carreyrou's book, in development at Apple TV+ with Jennifer Lawrence attached to star

See also

• Theranos
• Sunny Balwani
• Corporate fraud
• Silicon Valley

External links

• U.S. V. Elizabeth Holmes, et al. - U.S. Department of Justice case page